Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other Non-Current Assets: 2017-2020

Historic Other Non-Current Assets for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to $1.3 million.

  • Cogent Biosciences' Other Non-Current Assets rose 62.23% to $2.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.0 million, marking a year-over-year increase of 62.23%. This contributed to the annual value of $1.3 million for FY2020, which is negligibly% changed negligibly from last year.
  • As of FY2020, Cogent Biosciences' Other Non-Current Assets stood at $1.3 million, which was down 0.00% from $1.3 million recorded in FY2019.
  • Cogent Biosciences' Other Non-Current Assets' 5-year high stood at $1.4 million during FY2017, with a 5-year trough of $1.3 million in FY2018.
  • Its 3-year average for Other Non-Current Assets is $1.3 million, with a median of $1.3 million in 2020.
  • Data for Cogent Biosciences' Other Non-Current Assets shows a maximum YoY dropped of 8.59% (in 2018) over the last 5 years.
  • Cogent Biosciences' Other Non-Current Assets (Yearly) stood at $1.4 million in 2017, then declined by 8.59% to $1.3 million in 2018, then remained steady at $1.3 million in 2019, then remained steady at $1.3 million in 2020.